| Property | Value |
|---------|-------|
| **Gene Symbol** | PLK2 |
| **Full Name** | Polo-Like Kinase 2 |
| **Chromosomal Location** | 5q12.1 |
| **NCBI Gene ID** | [10769](https://www.ncbi.nlm.nih.gov/gene/10769) |
| **Ensembl ID** | ENSG00000145631 |
| **UniProt ID** | [Q9NYY3](https://www.uniprot.org/uniprot/Q9NYY3) |
| **Protein Family** | Polo-like kinase (PLK) family |
| **Protein Length** | 657 amino acids |
| **Molecular Weight** | ~71 kDa |
PLK2 (Polo-Like Kinase 2) is a serine/threonine protein kinase that plays critical roles in cellular homeostasis, synaptic function, and stress responses. The PLK family comprises five members (PLK1-5) in humans, with PLK2 being primarily expressed in neuronal tissue and playing essential roles in brain function . Variants in the PLK2 gene have been implicated in Parkinson's disease pathogenesis, where it influences alpha-synuclein phosphorylation, synaptic integrity, and cellular stress responses . This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
¶ Structure and Biochemistry
The PLK2 protein contains several functional domains essential for its kinase activity and cellular functions:
-
N-terminal Polo-box domain (PBD): Located at residues 350-650, this domain is responsible for substrate recognition and localization to specific cellular compartments. The PBD consists of two polo-box motifs that recognize phosphorylated serine/threonine residues on target proteins .
-
Kinase domain: The catalytic kinase domain (residues 1-300) contains the characteristic activation loop and ATP-binding pocket required for phosphorylation activity. PLK2 phosphorylates substrates on serine/threonine residues within specific consensus sequences.
-
C-terminal polo-box domain: Works in concert with the N-terminal PBD to mediate protein-protein interactions and substrate specificity.
-
Nuclear localization signals (NLS): Multiple NLS sequences facilitate PLK2 shuttling between cytoplasmic and nuclear compartments, allowing it to participate in diverse cellular processes.
PLK2 kinase activity is regulated by multiple mechanisms:
- Autophosphorylation: PLK2 can autophosphorylate itself, which may regulate its activity and stability
- Phosphorylation by upstream kinases: Akt and other kinases can modulate PLK2 activity
- Protein-protein interactions: Binding to specific partners modulates substrate access and localization
- Cellular stress: DNA damage, oxidative stress, and other stressors can activate PLK2
PLK2 is a stress-responsive kinase with multiple essential functions:
¶ Centrosome Function and Cell Cycle Regulation
PLK2 plays crucial roles in centrosome duplication and cell cycle progression:
- Centrosome duplication: PLK2 is essential for centriole copy number regulation during the cell cycle. It phosphorylates key substrates involved in centriole duplication, ensuring proper mitotic spindle formation .
- Cell cycle checkpoint: PLK2 participates in DNA damage response pathways, being activated by ATM/ATR kinases in response to genotoxic stress .
- G1/S transition: PLK2 helps regulate the G1 to S phase transition, with its expression being cell cycle-dependent.
PLK2 has emerged as a critical regulator of synaptic plasticity and neuronal connectivity:
- Synaptic plasticity: PLK2 is involved in long-term potentiation (LTP) and long-term depression (LTD), key cellular correlates of learning and memory. It phosphorylates synaptic proteins that regulate spine morphology and synaptic strength.
- Synaptic vesicle trafficking: PLK2 modulates the trafficking of synaptic vesicles, affecting neurotransmitter release and recycling .
- Dendritic spine maintenance: PLK2 helps maintain dendritic spine integrity through phosphorylation of cytoskeletal regulatory proteins.
As a stress-responsive kinase, PLK2 participates in DNA damage repair:
- ATM/ATR activation: In response to DNA double-strand breaks, ATM activates PLK2, which then phosphorylates downstream effectors .
- Cell cycle arrest: PLK2 contributes to p53-dependent cell cycle arrest following DNA damage.
- Apoptosis regulation: PLK2 can promote apoptosis in severely damaged cells through phosphorylation of pro-apoptotic proteins.
PLK2 plays important roles in cellular quality control through autophagy:
- Autophagy initiation: PLK2 phosphorylates components of the autophagy initiation complex, regulating the formation of autophagosomes .
- Lysosomal function: PLK2 affects lysosomal activity and function, impacting the final stage of autophagy .
- Protein homeostasis: Through autophagy regulation, PLK2 helps maintain cellular protein homeostasis.
PLK2 exhibits distinct expression patterns:
- Brain: High expression in the substantia nigra, hippocampus, cortex, and cerebellum
- Neuronal cells: Particularly enriched in dopaminergic neurons, pyramidal neurons, and cerebellar Purkinje cells
- Lower expression: Detectable in non-neuronal tissues including heart, kidney, and testis
- Developmental regulation: PLK2 expression increases during brain development, peaking in adulthood
PLK2 has emerged as an important player in Parkinson's disease pathogenesis through multiple mechanisms:
One of the most significant contributions of PLK2 to PD pathogenesis involves its ability to phosphorylate alpha-synuclein:
- Serine-129 phosphorylation: PLK2 phosphorylates alpha-synuclein at Ser129, a modification highly enriched in Lewy bodies in PD brain . This phosphorylation promotes alpha-synuclein aggregation and toxicity.
- Aggregation modulation: Phosphorylated alpha-synuclein shows increased propensity to form oligomers and fibrils, the building blocks of Lewy bodies.
- Cellular distribution: PLK2-mediated phosphorylation affects the subcellular localization of alpha-synuclein, potentially facilitating its spread between neurons.
Multiple studies have identified PLK2 variants as risk factors for PD:
- Common variants: Single nucleotide polymorphisms (SNPs) in the PLK2 gene region have been associated with increased PD risk in genome-wide association studies .
- Population-specific effects: Different allele frequencies have been observed across populations, with some variants showing stronger effects in specific ethnic groups .
- Haploinsufficiency: Reduced PLK2 expression due to copy number variants or regulatory polymorphisms may contribute to PD risk .
PLK2 dysfunction particularly affects dopaminergic neurons in the substantia nigra pars compacta:
- Enhanced stress sensitivity: PLK2-deficient dopaminergic neurons show increased vulnerability to oxidative stress and mitochondrial toxins.
- Mitochondrial dysfunction: PLK2 regulates mitochondrial quality control, and its dysfunction contributes to mitochondrial defects observed in PD .
- Synaptic dysfunction: PLK2 deficiency leads to impaired synaptic vesicle trafficking and neurotransmitter release in dopaminergic neurons.
PLK2 contributes to neuroinflammatory processes in PD:
- Microglial activation: PLK2 modulates microglial inflammatory responses, affecting cytokine release and phagocytic activity .
- Inflammasome regulation: PLK2 participates in NLRP3 inflammasome activation, influencing the inflammatory milieu in PD brain.
- Peripheral inflammation: PLK2 may affect peripheral immune responses that intersect with central nervous system inflammation.
While most extensively studied in PD, PLK2 also plays roles in Alzheimer's disease:
- Tau phosphorylation: PLK2 can phosphorylate tau protein, potentially contributing to neurofibrillary tangle formation.
- Synaptic loss: PLK2 dysfunction contributes to the synaptic deficits characteristic of AD.
- Cell cycle re-entry: Aberrant PLK2 expression may promote inappropriate cell cycle re-entry in neurons, a feature of AD pathogenesis.
PLK2 has been implicated in ALS through:
- Motor neuron vulnerability: PLK2 expression is altered in ALS motor neurons
- Stress response: PLK2's role in cellular stress responses may be particularly relevant in ALS pathogenesis
- Protein homeostasis: PLK2-mediated autophagy regulation may affect aggregation of ALS-associated proteins
The involvement of PLK2 in multiple aspects of neurodegeneration makes it an attractive therapeutic target:
Small molecule PLK2 inhibitors have been explored:
- Rationale: Reducing PLK2 activity may decrease alpha-synuclein phosphorylation and aggregation
- Challenges: PLK2 has essential functions in neurons, requiring careful dosing to avoid adverse effects
- Selectivity: Developing inhibitors that selectively target PLK2 over other PLK family members is important
- PLK2 expression modulation: Viral vector-mediated delivery to modulate PLK2 expression in target brain regions
- Allele-specific targeting: For patients with specific PLK2 risk variants, allele-specific approaches may be applicable
PLK2 may serve as a biomarker for neurodegeneration:
- Expression changes: PLK2 expression is altered in PD brain and peripheral tissues
- Activity markers: Kinase activity measurements could potentially track disease progression
- Genetic testing: PLK2 variant screening may aid in risk stratification
Several animal models have been developed to study PLK2 function:
- Knockout mice: PLK2 knockout mice show developmental abnormalities and increased susceptibility to stress
- Transgenic models: Mouse models with PLK2 overexpression or mutant variants
- Conditional knockouts: Tissue-specific and inducible models for studying PLK2 function in specific cell types
- Neuronal cultures: Primary neurons from rodent and human sources
- iPSC-derived models: Induced pluripotent stem cells differentiated into dopaminergic neurons
- Cell lines: Reporter cell lines for PLK2 activity monitoring
PLK2 interacts with multiple proteins relevant to neurodegeneration:
| Partner |
Interaction Type |
Functional Consequence |
| Alpha-synuclein |
Phosphorylation substrate |
Promotes aggregation |
| p53 |
Phosphorylation |
Cell cycle regulation |
| MDM2 |
Protein-protein |
Degradation control |
| Beclin-1 |
Phosphorylation |
Autophagy regulation |
| Synapsin |
Phosphorylation |
Synaptic function |
| VHL |
Protein-protein |
Tumor suppression |
PLK2 integrates cellular stress signals:
- Oxidative stress: Activated by ROS, contributes to antioxidant responses
- DNA damage: Part of the ATM/ATR-p53 pathway
- ER stress: Activated during unfolded protein response
- G1/S checkpoint: PLK2 helps enforce cell cycle arrest in stressed cells
- Mitotic regulation: Coordinates centrosome function
- Apoptosis: Can promote or inhibit cell death depending on context
- Genetic testing: PLK2 variants may be included in PD genetic panels
- Expression analysis: PLK2 mRNA and protein levels in peripheral blood mononuclear cells
- Activity assays: Emerging technologies for kinase activity measurement
Key areas for future investigation include:
- Mechanism elucidation: Detailed understanding of how PLK2 variants contribute to disease
- Biomarker development: Validating PLK2 as a disease biomarker
- Therapeutic targeting: Developing safe and effective PLK2 modulators
- Model systems: Improving animal and cellular models for drug testing
PLK2 shows high evolutionary conservation across species:
- Humans: 657 amino acids
- Mice: 653 amino acids, 87% identity
- Zebrafish: 648 amino acids, 72% identity
- Drosophila: 548 amino acids, 58% identity
- C. elegans: 501 amino acids, 45% identity
The kinase domain and Polo-box domains are highly conserved, indicating preserved functional mechanisms:
- Kinase domain: 94% identity between human and mouse
- PBD domain: 89% identity between human and mouse
- Regulatory regions: More divergent, allowing species-specific regulation
PLK2 contributes to protein aggregation in several ways:
- Alpha-synuclein phosphorylation: Direct phosphorylation at Ser129 promotes misfolding
- Chaperone dysfunction: PLK2 can affect molecular chaperone function
- Proteostasis disruption: Altered PLK2 affects protein quality control systems
PLK2 plays important roles in membrane trafficking:
- Endocytic pathway: Regulates early endosome function and trafficking
- Lysosomal transport: Affects delivery of materials to lysosomes
- Synaptic vesicle cycling: Critical for neurotransmitter release and recycling
PLK2 influences calcium homeostasis:
- ER calcium stores: Affects calcium release from endoplasmic reticulum
- Mitochondrial calcium: Modulates mitochondrial calcium uptake
- Calcium signaling: Impacts synaptic calcium signals during plasticity
Several key questions remain:
- Cell-type specificity: Why are dopaminergic neurons particularly vulnerable to PLK2 dysfunction?
- Temporal dynamics: How does PLK2 activity change during disease progression?
- Compensatory mechanisms: What pathways compensate for PLK2 loss?
Future therapeutic strategies include:
- Kinase modulators: Developing selective PLK2 activators or inhibitors
- Gene therapy: Viral vector-mediated PLK2 expression modulation
- Combination approaches: Targeting PLK2 alongside other PD pathways
PLK2 represents a critical node in the molecular networks governing neuronal survival and function. Its role in alpha-synuclein phosphorylation, synaptic plasticity, and cellular stress responses makes it a significant contributor to Parkinson's disease pathogenesis. The identification of PLK2 genetic variants as risk factors for PD further underscores its importance. Understanding PLK2 biology offers insights into disease mechanisms and potential therapeutic approaches. As research progresses, PLK2-targeted strategies may emerge as valuable components of comprehensive neurodegeneration treatment.